BioStem Technologies, Inc.
BSEM
$11.26
-$0.6979-5.84%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 210.39M | 131.34M | 131.34M | 57.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 210.39M | 131.34M | 131.34M | 57.91M |
| Cost of Revenue | -- | 10.86M | 6.94M | 6.94M | 3.40M |
| Gross Profit | -- | 199.54M | 124.39M | 124.39M | 54.51M |
| SG&A Expenses | -- | 177.73M | 112.94M | 112.94M | 54.61M |
| Depreciation & Amortization | -- | 217.40K | 218.40K | 216.60K | 222.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 189.78M | 120.63M | 120.63M | 58.74M |
| Operating Income | -- | 20.61M | 10.70M | 10.70M | -828.50K |
| Income Before Tax | -- | 19.53M | 8.84M | 8.84M | -2.69M |
| Income Tax Expenses | -- | 5.83M | 3.50M | 3.50M | 1.18M |
| Earnings from Continuing Operations | -- | 13.70 | 5.34 | 5.34 | -3.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 13.70M | 5.34M | 5.34M | -3.88M |
| EBIT | -- | 20.61M | 10.70M | 10.70M | -828.50K |
| EBITDA | -- | 20.83M | 10.91M | 10.91M | -611.70K |
| EPS Basic | -- | 0.83 | 0.30 | 0.30 | -0.31 |
| Normalized Basic EPS | -- | 0.77 | 0.38 | 0.38 | -0.09 |
| EPS Diluted | -- | 0.61 | 0.14 | 0.18 | -0.34 |
| Normalized Diluted EPS | -- | 0.59 | 0.25 | 0.28 | -0.11 |
| Average Basic Shares Outstanding | -- | 64.14M | 61.31M | 61.31M | 58.27M |
| Average Diluted Shares Outstanding | -- | 77.01M | 73.46M | 69.37M | 61.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |